Adamczyk, B.; Morawiec, N.; Kwinta, R.; Rakoca, M.; Wawrzyniak, S.; Zalejska-Fiolka, J.; Sowa, A.; Sawa, K.; Adamczyk-Sowa, M.
Evaluation of Selected Serum Adipocytokines in Patients with Relapsing–Remitting Multiple Sclerosis Treated with Immunomodulatory Second-Line Drugs. Int. J. Mol. Sci. 2025, 26, 8070.
https://doi.org/10.3390/ijms26168070
AMA Style
Adamczyk B, Morawiec N, Kwinta R, Rakoca M, Wawrzyniak S, Zalejska-Fiolka J, Sowa A, Sawa K, Adamczyk-Sowa M.
Evaluation of Selected Serum Adipocytokines in Patients with Relapsing–Remitting Multiple Sclerosis Treated with Immunomodulatory Second-Line Drugs. International Journal of Molecular Sciences. 2025; 26(16):8070.
https://doi.org/10.3390/ijms26168070
Chicago/Turabian Style
Adamczyk, Bożena, Natalia Morawiec, Robert Kwinta, Michał Rakoca, Sławomir Wawrzyniak, Jolanta Zalejska-Fiolka, Agata Sowa, Ksawier Sawa, and Monika Adamczyk-Sowa.
2025. "Evaluation of Selected Serum Adipocytokines in Patients with Relapsing–Remitting Multiple Sclerosis Treated with Immunomodulatory Second-Line Drugs" International Journal of Molecular Sciences 26, no. 16: 8070.
https://doi.org/10.3390/ijms26168070
APA Style
Adamczyk, B., Morawiec, N., Kwinta, R., Rakoca, M., Wawrzyniak, S., Zalejska-Fiolka, J., Sowa, A., Sawa, K., & Adamczyk-Sowa, M.
(2025). Evaluation of Selected Serum Adipocytokines in Patients with Relapsing–Remitting Multiple Sclerosis Treated with Immunomodulatory Second-Line Drugs. International Journal of Molecular Sciences, 26(16), 8070.
https://doi.org/10.3390/ijms26168070